Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-23

Clinical Trial Update: Subthalamic Stimulation in Tourette's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating subthalamic stimulation for Tourette syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Tourette's Syndrome, Tourette Syndrome | Phase 2 | Status: COMPLETED